Evidence map›Paper›PMID 38611364›Full record

ArticleFoods (Basel, Switzerland)2024

The Use of

Maria-Evangelia Filippousi, Ioanna Chalvantzi, Athanasios Mallouchos, Ioannis Marmaras, Georgios Banilas, Aspasia Nisiotou

Open access · goldAbstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Selection of Non-Microorganisms · 2025
    Article
  5. Microbial communities from distinctFrontiers in fungal biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Maria-Evangelia FilippousiInstitute of Technology of Agricultural Products, Hellenic Agricultural Organization "Dimitra", Sofokli Venizelou 1, 14123 Lykovryssi, Greece.
Ioanna ChalvantziInstitute of Technology of Agricultural Products, Hellenic Agricultural Organization "Dimitra", Sofokli Venizelou 1, 14123 Lykovryssi, Greece.
Athanasios MallouchosLaboratory of Food Chemistry and Analysis, Department of Food Science and Human Nutrition, Agricultural University of Athens, Iera Odos 75, 11855 Athens, Greece.ORCID 0000-0003-1503-1064
Ioannis MarmarasInstitute of Technology of Agricultural Products, Hellenic Agricultural Organization "Dimitra", Sofokli Venizelou 1, 14123 Lykovryssi, Greece.
Georgios BanilasDepartment of Wine, Vine and Beverage Sciences, University of West Attica, Spyridonos 28, 12243 Athens, Greece.
Aspasia NisiotouInstitute of Technology of Agricultural Products, Hellenic Agricultural Organization "Dimitra", Sofokli Venizelou 1, 14123 Lykovryssi, Greece.
Hellenic Aerospace Industry (Greece) · GRAgricultural University of Athens · GRUniversity of West Attica · GR

Funding

European Regional Development Fund of the European Union and Greek national funds through the Regional Operational Programme "Western Greece" MIS 5040235
6 · The paper itself

Abstract

In view of climate change and the increasingly antagonistic wine market, the exploitation of native genetic resources is revisited in relation to sustainable wine production. 'Sideritis' is a late-ripening Greek grape variety, which is quite promising for counteracting wine quality issues associated with the annual temperature rise. The aim of this study was to improve the quality and to enhance the aroma of 'Sideritis' wine through the use of native yeasts. To improve vinification,

Indexed as

Hanseniaspora opuntiaenon-Saccharomyceswine chemical profilewine fermentationyeast starter cultures

Identifiers

PMID38611364
PMCPMC11011255
OpenAlexW4393357804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.